Axogen, Inc. — Director's Dealing 2024

Jan 11, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2024-01-01

Reporting Person: Kemp Jens (Chief Marketing Officer)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	30000	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Employee Stock Option (right to purchase)	$8.16	2033-03-01	Common Stock (60000)		Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F2: All shares of Axogen, Inc. common stock underlying the employee stock option will be fully vested on March 1, 2027 (4 years from the option grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 1, 2025 (24 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.